Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Minority Interest (2016 - 2025)

Marimed (MRMD) has disclosed Minority Interest for 13 consecutive years, with -$1.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Minority Interest fell 5.36% to -$1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.8 million, a 5.36% decrease, with the full-year FY2024 number at -$1.8 million, down 6.18% from a year prior.
  • Minority Interest was -$1.8 million for Q3 2025 at Marimed, down from -$1.8 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of -$569574.0 in Q1 2021 to a low of -$1.8 million in Q3 2025.
  • A 5-year average of -$1.5 million and a median of -$1.6 million in 2022 define the central range for Minority Interest.
  • Biggest YoY gain for Minority Interest was 5.39% in 2022; the steepest drop was 182.84% in 2022.
  • Marimed's Minority Interest stood at -$1.6 million in 2021, then rose by 3.33% to -$1.5 million in 2022, then fell by 9.2% to -$1.6 million in 2023, then dropped by 6.18% to -$1.8 million in 2024, then decreased by 4.39% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Minority Interest are -$1.8 million (Q3 2025), -$1.8 million (Q2 2025), and -$1.8 million (Q1 2025).